Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
Andrew Boulle;Michael Schomaker;Margaret T. May;Robert S. Hogg;Bryan E. Shepherd;Susana Monge;Olivia Keiser;Fiona C. Lampe;Janet Giddy;James Ndirangu;Daniela Garone;Matthew Fox;Suzanne M. Ingle;Peter Reiss;Francois Dabis;Dominique Costagliola;Antonella Castagna;Kathrin Ehren;Colin Campbell;M. John Gill;Michael Saag;Amy C. Justice;Jodie Guest;Heidi M. Crane;Matthias Egger;Jonathan A. C. Sterne;
plos medicine2014Vol. 11pp. e1001718-
328
boulle2014plosmortality
Abstract
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary